Olema Pharmaceuticals, Inc. (OLMA) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Join SI Premium – FREE
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q3 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
- Rosenblatt Reiterates Buy Rating on NVIDIA (NVDA) into Earnings
- Evercore ISI Adds Dell (DELL) to Tactical Outperform List
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
